Literature DB >> 16113556

Effect of betamethasone administration on fetal heart rate tracing: a blinded longitudinal study.

Sigi Rotmensch1, Shaul Lev, Mihal Kovo, Zeev Efrat, Zvi Zahavi, Nirit Lev, Claudio Celentano, Zion Ben-Rafael.   

Abstract

OBJECTIVE: Computerized fetal heart rate (FHR) analysis revealed that antenatal corticosteroids transiently suppress multiple parameters of fetal well-being, potentially leading to the erroneous diagnosis of fetal distress and to unnecessary iatrogenic delivery of premature infants. Our aim was to determine whether clinicians who visually analyze FHR tracings detect these suppressive effects, thereby potentially affecting their clinical management decisions.
METHODS: Singleton pregnancies admitted for preterm labor between 26 and 34 weeks' gestation received two doses of betamethasone, 24 h apart, and were monitored daily between 16:00 and 19:00 h for 5 days. FHR tracings were randomly coded and presented in a non-consecutive order to four clinicians, who were unaware of the time of steroid administration. FHR baseline, FHR variability, number of accelerations and amplitude of maximal FHR acceleration were determined. Variability was scored semiquantitatively based on a modified Hon score. Analysis of variance (ANOVA) with repeated measures was used for primary analysis and followed up with the Wald test of significance. Corrections for multiple comparisons were made and only p < 0.005 considered significant. ANOVA was also used to assess the uniformity of trend in the interpretation by the four examiners for each given day.
RESULTS: Baseline FHR was elevated, FHR variability was decreased, and the number of accelerations decreased on day 1 (p < 0.0001; p < 0.0001; p < 0.0001) and day 2 (p > 0.0001; p < 0.0001; p < 0.0001) in comparison to day 0. On day 3, the FHR baseline, variability and number of accelerations returned to pre-exposure values (p = NS). The maximal amplitude of FHR accelerations showed a trend towards reduction (p = 0.08). Subgroup analysis by gestational age (group I = 26-30 weeks and group II = 30-34 weeks) showed the same response patterns and significance levels for both groups.
CONCLUSIONS: Betamethasone causes profound, but transient, suppression of FHR parameters, which can mimic fetal distress. This effect is clinically recognized by visual FHR analysis. Clinicians need to be aware of this phenomenon, in order to avoid unwarranted iatrogenic delivery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113556     DOI: 10.1159/000086815

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  3 in total

1.  Full-term-pregnancy effects of antenatal betamethasone administration on short-term variation as assessed by computerized cardiotocography.

Authors:  Juan Piazze; Kathleen Comalli Dillon; Cerekja Albana
Journal:  J Prenat Med       Date:  2012-04

2.  Fetal heart rate monitoring patterns in women with amniotic fluid proteomic profiles indicative of inflammation.

Authors:  Catalin S Buhimschi; Sonya Abdel-Razeq; Michael Cackovic; Christian M Pettker; Antonette T Dulay; Mert Ozan Bahtiyar; Eduardo Zambrano; Ryan Martin; Errol R Norwitz; Vineet Bhandari; Irina A Buhimschi
Journal:  Am J Perinatol       Date:  2008-05-29       Impact factor: 1.862

3.  Judicious use of antenatal glucocorticoids: putting the risks into the balance.

Authors:  J Verhaeghe
Journal:  Facts Views Vis Obgyn       Date:  2011
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.